February 2014 FDA Recall Drug by Teva Pharmaceuticals Usa
D-1190-2014 - Failed Impurity/Degradation Specification; for 17-BMP at the 9 and 18 month stability time point

This Class III drug recall was voluntarily initiated by Teva Pharmaceuticals Usa on February 11, 2014 for the product Drug. The FDA reported the reason for recall as failed impurity/degradation specification; for 17-bmp at the 9 and 18 month stability time point. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1190-2014

Reason for Recall
Failed Impurity/Degradation Specification; for 17-BMP at the 9 and 18 month stability time point
Initiated
02-11-2014
Reported
04-09-2014
Quantity
257,832 cylinders

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Teva Pharmaceuticals USA
QVAR¿ (beclomethasone dipropionate HFA), C4 INHALATION AEROSOL in Aluminum Cylinders, Mktd by: Teva Respiratory, LLC, Horsham, PA 19044 Mfd by: 3M Drug Delivery Systems, Northridge, CA 91324.

Batch or Lot Expiration Information

Lot# lot 120088, exp.3/2014, NDC 59310-202-40, 40 mcg,8.7g / 120 metered inhalations, lot 120491, exp. 10/2014, NDC 59310-175-41,40 mcg,7.3g / 100 metered inhalations